Skip to content Skip to menu

New member appointees to the Medicines Australia Board

Monday, 19 December 2016

Media Release

The Chairman of Medicines Australia, Mr Wes Cook, would like to announce that Melissa McGregor and Bruce Goodwin have been voted to the Board of Directors.

Melissa McGregor is the Managing Director of Pfizer in Australia & New Zealand, while Bruce Goodwin is the Managing Director of Janssen Pharmaceuticals in Australia and New Zealand (a subsidiary of Johnson & Johnson).

Their appointments follow the recent departures of Geoff McDonald (GSK) and James Priour (Amgen) from the Board. Both appointees will hold their positions until the next Annual General Meeting, to be held in October 2017, when all Board positions will be up for nomination.

Mr Goodwin previously served on the Medicines Australia Board between 2009 and 2012. He also served for two years as the Vice-Chairman of the Japanese-based executive committee of PhRMA while working as President of Janssen in Japan.

Ms McGregor was a Board member of the New Zealand industry body when she was recently running Pfizer’s local operations.

“On behalf of the membership, I would like to congratulate both Melissa and Bruce on their successful nominations to the Medicines Australia Board,” said Mr Cook.

“To be nominated by your peers to represent the industry is a tremendous honour and I know both Bruce and Melissa will be valuable additions to the Board.”

“Combined, they bring five decades worth of experience in the pharmaceutical industry with much of that time in Australia.”

“Their experience in the sector will help them to play a vital role in the policy discussions that are critical to our members.”

“I look forward to working alongside Melissa and Bruce during what will be an important year for our industry,” said Mr Cook.

Medicines Australia Chief Executive, Milton Catelin said, “to have a strong members’ organisation you need a strong Board of Directors and Melissa and Bruce will not only meet that challenge they will help further strengthen the reputation of this important industry.”

“I have no doubt that I will be utilising their insights and experience as we meet the policy challenges over the year ahead.”

“On behalf of Medicines Australia I would like to congratulate them both on their appointments.”

Ms McGregor and Mr Goodwin will participate in their first Board meeting in February 2017.

Contact:

Natalie Wimmer
Phone: (02) 6122 8500
Email:
Natalie.Wimmer@medicinesaustralia.com.au

Top